Articles related to DEPRESSION

“When it comes to trying to work out this issue of sleep problems and depression, it is a classic chicken and the egg problem… The question is, when we look at what’s causing what, that’s not just an idle sort of thing to think about. It has direct treatment implications.”

“Don’t try to think yourself out of a dysregulated state; it’s a body thing.”

Rapid symptom improvement and sustained 4-week benefits distinguish Spravato monotherapy in treatment-resistant depression, with significant MADRS score reductions versus placebo.

The FDA-designated Class II recall affects specific duloxetine lots where exposure may lead to “temporary or medically reversible health consequences or where the probability of serious adverse health consequences is remote.”

A new network meta-analysis reveals that high-dose psilocybin may be as effective as escitalopram for treating depressive symptoms, with a standardized mean difference of 0.31 compared to placebo in antidepressant trials.

Clinicians treating cancer and kidney disease patients prescribed antidepressants at rates similar to outpatient psychiatrists, highlighting the prevalence of depression management across specialties.